Literature DB >> 10721011

A nice challenge for health economics.

J Hutton, A Maynard.   

Abstract

Mesh：

Year:  2000        PMID： 10721011     DOI： 10.1002/(sici)1099-1050(200003)9:2<89::aid-hec504>3.0.co;2-g

Source DB:  PubMed          Journal:  Health Econ        ISSN： 1057-9230            Impact factor:   3.046


× No keyword cloud information.
  6 in total

1.  NICE methodological guidelines and decision making in the National Health Service in England and Wales.

Authors:  Amiram Gafni; Stephen Birch
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

2.  The 'NICE' approach to technology assessment: an economics perspective.

Authors:  Stephen Birch; Amiram Gafni
Journal:  Health Care Manag Sci       Date:  2004-02

Review 3.  Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle.

Authors:  R S Taylor; M F Drummond; G Salkeld; S D Sullivan
Journal:  BMJ       Date:  2004-10-23

4.  Evaluating health care programs by combining cost with quality of life measures: a case study comparing capitation and fee for service.

Authors:  Richard Grieve; Jasjeet S Sekhon; Teh-Wei Hu; Joan R Bloom
Journal:  Health Serv Res       Date:  2008-03-17       Impact factor: 3.402

Review 5.  The NICE cost-effectiveness threshold: what it is and what that means.

Authors:  Christopher McCabe; Karl Claxton; Anthony J Culyer
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

6.  The individual in mainstream health economics: a case of Persona Non-grata.

Authors:  John B Davis; Robert McMaster
Journal:  Health Care Anal       Date:  2007-04-05
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.